Sangamo Therapeutics Announces Fourth Quarter and Full Year 2020 Conference Call and Webcast

Rhea-AI Summary

Sangamo Therapeutics, Inc. (Nasdaq: SGMO) has announced the release of its fourth quarter and full year 2020 financial results, scheduled for February 24, 2021, after market close. A conference call will follow at 5:00 p.m. ET, where the company aims to review financial results and provide business updates. Participants can join via telephone or webcast. The call can be accessed using specific dial-in numbers for domestic and international callers, and a replay will be available for one week post-call.

Positive

• Scheduled release of financial results may provide insights into company performance
• Public conference call offers transparency and direct communication with investors

Negative

• None.

Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that the Company has scheduled the release of its fourth quarter and full year 2020 financial results after the market closes on Wednesday, February 24, 2021. The press release will be followed by a conference call at 5:00 p.m. ET, which will be open to the public via telephone and webcast. During the conference call, the Company will review its financial results and provide business updates.

The conference call dial-in numbers are (877) 377-7553 for domestic callers and (678) 894-3968 for international callers. The conference ID number for the call is 1795427. Participants may access the live webcast via a link on the Sangamo Therapeutics website in the Investors and Media section under Events and Presentations. A conference call replay will be available for one week following the conference call. The conference call replay numbers for domestic and international callers are (855) 859-2056 and (404) 537-3406, respectively. The conference ID number for the replay is 1795427.

About Sangamo Therapeutics

Sangamo Therapeutics is committed to translating ground-breaking science into genomic medicines with the potential to transform patients’ lives using gene therapy, cell therapy, and genome engineering. For more information about Sangamo, visit www.sangamo.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210217005763/en/

FAQ

When will Sangamo Therapeutics release their Q4 and full year 2020 financial results?

Sangamo Therapeutics will release their financial results on February 24, 2021, after market close.

What time is the Sangamo Therapeutics conference call?

The conference call is scheduled for 5:00 p.m. ET on February 24, 2021.

How can I listen to the Sangamo Therapeutics conference call?

The conference call can be accessed via telephone or webcast, with specific dial-in numbers provided in the press release.

Is there a replay available for the Sangamo Therapeutics conference call?

Yes, a replay of the conference call will be available for one week after the event.

What is the conference ID for the Sangamo Therapeutics call?

The conference ID number is 1795427.